Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04400903 · ClinicalTrials.gov registry record
Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer
A clinical trial, sponsored by OHSU Knight Cancer Institute.
- Terminated
- Registry status
- 110
- Enrollment target
NCT04400903 is a clinical trial that was terminated before completion, run by OHSU Knight Cancer Institute. The registered enrollment target is 110 participants.
The verdict
NCT04400903 was terminated before completion, sponsored by OHSU Knight Cancer Institute.
- TERMINATED
- Registry status
- 110 participants
- Enrollment target
Study Summary
This study examines heart rate monitoring variability for the early detection of pancreatic cancer. Pancreatic cancer is a very difficult disease to detect early. This study is being done to observe the heart rate variability in patients with pancreatic cancer compared to undiagnosed individuals with increased risk of developing pancreatic cancer. This may help researchers determine if pancreatic occurrences/recurrences (chance of coming back) can be detected sooner through monitoring heart rate and activity.
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- DEVICE Activity Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-09-21 |
| Est. Completion | 2022-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04400903
The ClinicalTrials.gov registry entry for NCT04400903 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT04400903 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04400903 about?
NCT04400903 is a clinical study titled "Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer". This study examines heart rate monitoring variability for the early detection of pancreatic cancer. Pancreatic cancer is a very difficult disease to detect early. This study is being done to observe the heart rate variability in patients with pancreatic cancer compared to undiagnosed individuals wit...
What is the current status of trial NCT04400903?
This trial is currently terminated. The enrollment target is 110 participants. The study started on 2020-09-21. Estimated completion is 2022-09-30.
What interventions are being tested in trial NCT04400903?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Activity Monitor (DEVICE).
Who is sponsoring clinical trial NCT04400903?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.